David Qualtrough
Impact in
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
- Pharmacology top 5%
- Inflammatory mediators and NSAID effects
Papers in
-
- Eicosanoids and Hypertension Pharmacology 3
-
- Cancer, Hypoxia, and Metabolism 5
- Co-authors
- Christos ParaskevaAnn C. WilliamsAbderrahmane KaidiSimon ChellAndrea BudaWilliam GaffieldAndrew HermanIan R. Witherden
- Journals
- British Journal of Cancer (2 papers)Cancers (2 papers)International Journal of Cancer (2 papers)Cancer Research (2 papers)Biochemical Society Transactions (1 paper)
- Partner nations
- United KingdomUnited StatesSaudi Arabia
In The Last Decade
David Qualtrough
17 papers receiving 832 citations
Peers
Comparison fields: 5 of 87
- Cancer Research 244
- Pharmacology 222
- Biochemistry 76
- Oncology 199
- Genetics 176
Countries citing papers authored by David Qualtrough
This map shows the geographic impact of David Qualtrough's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Qualtrough with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Qualtrough more than expected).
Fields of papers citing papers by David Qualtrough
This network shows the impact of papers produced by David Qualtrough. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Qualtrough. The network helps show where David Qualtrough may publish in the future.
Co-authorship network
The 25 scholars most cited alongside David Qualtrough, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 5 | |
| 2 | 2023 | 6 | |
| 3 | 2020 | 10 | |
| 4 | 2020 | 13 | |
| 5 | 2017 | 12 | |
| 6 | 2015 | 28 | |
| 7 | 2015 | 26 | |
| 8 | 2011 | 20 | |
| 9 | 2009 | 27 | |
| 10 | 2007 | 32 | |
| 11 | 2007 | 61 | |
| 12 | 2006 | 126 | |
| 13 | 2006 | 252 | |
| 14 | 2005 | 20 | |
| 15 | 2004 | 138 | |
| 16 | 2002 | 51 | |
| 17 | 2002 | 25 |
About David Qualtrough
David Qualtrough is a scholar working on Biochemistry, Cancer Research, Pharmacology, Genetics and Oncology, having authored 17 papers that have together received 852 indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (5 papers), Inflammatory mediators and NSAID effects (5 papers), Estrogen and related hormone effects (4 papers), Hedgehog Signaling Pathway Studies (3 papers), Cancer-related Molecular Pathways (3 papers), Eicosanoids and Hypertension Pharmacology (3 papers), RNA modifications and cancer (2 papers) and Cancer Cells and Metastasis (2 papers). The work is most often cited by research in Cancer Research (244 citations), Pharmacology (222 citations), Biochemistry (76 citations), Oncology (199 citations) and Genetics (176 citations). David Qualtrough has collaborated with scholars based in United Kingdom, United States and Saudi Arabia. Frequent co-authors include Christos Paraskeva, Ann C. Williams, Abderrahmane Kaidi, Simon Chell, Andrea Buda, William Gaffield, Andrew Herman, Ian R. Witherden, Massimo Pignatelli and Takao Hinoi. Their work appears in journals such as British Journal of Cancer, Cancers, International Journal of Cancer, Cancer Research and Biochemical Society Transactions.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.